HRAS and angiosarcoma: Angiosarcoma studies have relied heavily on the use of in vitro systems including MS1 VEGF and MS1 SVR angiosarcoma cells, which show VEGF- and oncogenic H-Ras-dependent tumorigenicity, respectively14,15.